Aradigm Overview

  • Founded
  • 1991

Founded
  • Status
  • Private

  • Employees
  • 23

Employees
  • Latest Deal Type
  • Bankr. Admin/​Reorg

  • Financing Rounds
  • 13

Aradigm General Information

Description

Aradigm Corp is a United States based specialty pharmaceutical company. It develops and commercializes drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases. The company has respiratory inhalation products in preclinical and clinical development for the treatment of cystic fibrosis, bronchiectasis, biodefense, and tobacco smoking cessation. It derives revenue from the grants, collaboration agreements, and feasibility studies.

Contact Information

Website
www.aradigm.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Primary Office
  • 3929 Point Eden Way
  • Hayward, CA 94545
  • United States
+1 (510) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aradigm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Aradigm‘s full profile, request access.

Request a free trial

Aradigm Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Aradigm Corp is a United States based specialty pharmaceutical company. It develops and commercializes drugs delivered b
Drug Discovery
Hayward, CA
23 As of 2017
00000
0000000000.

000000

re dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur
0000 00000000
Cambridge, MA
00 As of 0000
00000
0000 0000-00-00
00000000 00000

000000

exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repr
0000 00000000
Cambridge, MA
00 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aradigm Competitors (25)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Merrimack Pharmaceuticals Formerly VC-backed Cambridge, MA 00 00000 00000000 00000
0000000 0000000000 Formerly VC-backed Cambridge, MA 00 00000 00000000 00000
00000000 000000000 Formerly VC-backed Lake Forest, IL 00 00000 000000000 00000
0000000 000000000 Corporation Warminster, PA 00 00000 000000000 00000
000-000 Corporate Backed or Acquired Vienna, VA 00 000.00 000000000 000.00
You’re viewing 5 of 25 competitors. Get the full list »

Aradigm Patents

Aradigm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2015244275-B2 Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria Inactive 08-Apr-2014 0000000000
AU-2015244275-A1 Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria Active 08-Apr-2014 0000000000
CA-2943049-A1 Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria Pending 08-Apr-2014 0000000000
US-20180092912-A1 Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria Active 08-Apr-2014 0000000000
US-20150283133-A1 Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria Active 08-Apr-2014 A61K31/496
To view Aradigm’s complete patent history, request access »

Aradigm Executive Team (12)

Name Title Board Seat Contact Info
James Blanchard Principal Scientist, Preclinical Development
You’re viewing 1 of 12 executive team members. Get the full list »

Aradigm Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aradigm Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Aradigm‘s full profile, request access.

Request a free trial